Project Number 1R43AG062058-01 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Development of CDK5-p25 modulator to treat Alzheimers Disease and Frontotemporal Dementia Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator WERNER, JOHN KENT Principal Investigator First Name JOHN KENT Principal Investigator Last Name WERNER Awardee Organization COGENTIS THERAPEUTICS, INC. Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-574: PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) FY Overall Cost $497,121 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
